As of 2025-07-19, the Relative Valuation of Kinnate Biopharma Inc (KNTE) is (52.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.65 USD, the upside of Kinnate Biopharma Inc based on Relative Valuation is -2078.1%.
The range of the Relative Valuation is (34.39) - (63.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 26.7x | 20.6x |
| Forward P/E multiples | 14.4x - 32.3x | 23.3x |
| Fair Price | (34.39) - (63.76) | (52.42) |
| Upside | -1397.7% - -2506.2% | -2078.1% |
| Date | P/E |